Study period | |||||||
---|---|---|---|---|---|---|---|
Enrollment | Run-in | Allocation | Post-location | Close-out | |||
Time point | 0 | 0 | 0 | Day1 | Day 2 | Day3 | Day 3 |
Enrollment | |||||||
Eligibility screen | x | ||||||
Informed consent | x | ||||||
Adjusting insulin doses | x | ||||||
Allocation | x | ||||||
Interventions | |||||||
A new infusion set | x | ||||||
CGM application | x | ||||||
Super Bolus, Normal Bolus | x | x | |||||
Assessments | |||||||
Anthropometric measurement (body weight, height, BMI) | x | ||||||
TDD, basal insulin | x | ||||||
HbA1c | x | ||||||
Blood glucose level 30, 60, 90, 120, 150, and 180 min after prandial bolus | x | x | |||||
Occurrence of hypoglycemia | x | x | |||||
Register records from CGM | x | ||||||
AUC, peak glucose, time to peak, glycemic rise, MAGE | x |